Rôle de l'herpèsvirus humain de type 6 dans le ... - Epublications

Young, L. S. & Murray, P. G. (2003). Epstein-Barr virus and oncogenesis: from latent genes to
tumours. Oncogene 22, 5108-5121.
Zheng, B., Fiumara, P., Li, Y. V., Georgakis, G., Snell, V., Younes, M., Vauthey, J. N.,
Carbone, A. & Younes, A. (2003). MEK/ERK pathway is aberrantly active in Hodgkin
disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell
proliferation and survival. Blood 102, 1019-1027.
Zheng, B., Georgakis, G. V., Li, Y., Bharti, A., McConkey, D., Aggarwal, B. B. & Younes,
A. (2004). Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341
in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB
mutations or activation of the CD30, CD40, and RANK receptors. Clin Cancer Res 10,
3207-3215.
Zhou, Y., Attygalle, A. D., Chuang, S. S., Diss, T., Ye, H., Liu, H., Hamoudi, R. A., Munson,
P., Bacon, C. M., Dogan, A. & Du, M. Q. (2007). Angioimmunoblastic T-cell
lymphoma: histological progression associates with EBV and HHV6B viral load. Br J
Haematol 138, 44-53.
Zhou, Y., Chang, C. K., Qian, G., Chandran, B. & Wood, C. (1994). trans-activation of the
HIV promoter by a cDNA and its genomic clones of human herpesvirus-6. Virology 199,
311-322.
182